Population Pharmacokinetic/Pharmacodynamic Modeling of Depot Testosterone Cypionate in Healthy Male Subjects

Youwei Bi, Paul J. Perry, Michael Ellerby, Daryl J Murry

Research output: Contribution to journalArticle

Abstract

A randomized, double-blind clinical trial was conducted to investigate long-term abuse effects of testosterone cypionate (TC). Thirty-one healthy men were randomized into a dose group of 100, 250, or 500 mg/wk and received 14 weekly injections of TC. A pharmacokinetic/pharmacodynamic (PK/PD) model was developed to characterize testosterone concentrations and link exposure to change in luteinizing hormone and spermatogenesis following long-term TC administration. A linear one-compartment model best described the concentration-time profile of total testosterone. The population mean estimates for testosterone were 2.6 kL/day for clearance and 14.4 kL for volume of distribution. Weight, albumin, and their changes from baseline were identified as significant covariates for testosterone. The estimated potency of total testosterone (tT) with respect to suppression of luteinizing hormone (LH) synthesis was 9.33 ng/mL. Simulation based on the indirect response model suggests the suppression of endogenous testosterone secretion, LH synthesis, and spermatogenesis was more severe and of greater duration in the 250 mg and the 500 mg dose groups.

Original languageEnglish (US)
Pages (from-to)259-268
Number of pages10
JournalCPT: Pharmacometrics and Systems Pharmacology
Volume7
Issue number4
DOIs
StatePublished - Apr 2018

Fingerprint

Pharmacodynamics
Pharmacokinetics
Hormones
Testosterone
Healthy Volunteers
Dose
Luteinizing Hormone
Modeling
Synthesis
Population
Compartment Model
Secretion
Spermatogenesis
Clearance
Clinical Trials
Covariates
Baseline
Injection
Model
Estimate

ASJC Scopus subject areas

  • Modeling and Simulation
  • Pharmacology (medical)

Cite this

Population Pharmacokinetic/Pharmacodynamic Modeling of Depot Testosterone Cypionate in Healthy Male Subjects. / Bi, Youwei; Perry, Paul J.; Ellerby, Michael; Murry, Daryl J.

In: CPT: Pharmacometrics and Systems Pharmacology, Vol. 7, No. 4, 04.2018, p. 259-268.

Research output: Contribution to journalArticle

@article{03e9a40977314d3487cc8b4ba183e8b6,
title = "Population Pharmacokinetic/Pharmacodynamic Modeling of Depot Testosterone Cypionate in Healthy Male Subjects",
abstract = "A randomized, double-blind clinical trial was conducted to investigate long-term abuse effects of testosterone cypionate (TC). Thirty-one healthy men were randomized into a dose group of 100, 250, or 500 mg/wk and received 14 weekly injections of TC. A pharmacokinetic/pharmacodynamic (PK/PD) model was developed to characterize testosterone concentrations and link exposure to change in luteinizing hormone and spermatogenesis following long-term TC administration. A linear one-compartment model best described the concentration-time profile of total testosterone. The population mean estimates for testosterone were 2.6 kL/day for clearance and 14.4 kL for volume of distribution. Weight, albumin, and their changes from baseline were identified as significant covariates for testosterone. The estimated potency of total testosterone (tT) with respect to suppression of luteinizing hormone (LH) synthesis was 9.33 ng/mL. Simulation based on the indirect response model suggests the suppression of endogenous testosterone secretion, LH synthesis, and spermatogenesis was more severe and of greater duration in the 250 mg and the 500 mg dose groups.",
author = "Youwei Bi and Perry, {Paul J.} and Michael Ellerby and Murry, {Daryl J}",
year = "2018",
month = "4",
doi = "10.1002/psp4.12287",
language = "English (US)",
volume = "7",
pages = "259--268",
journal = "CPT: Pharmacometrics and Systems Pharmacology",
issn = "2163-8306",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Population Pharmacokinetic/Pharmacodynamic Modeling of Depot Testosterone Cypionate in Healthy Male Subjects

AU - Bi, Youwei

AU - Perry, Paul J.

AU - Ellerby, Michael

AU - Murry, Daryl J

PY - 2018/4

Y1 - 2018/4

N2 - A randomized, double-blind clinical trial was conducted to investigate long-term abuse effects of testosterone cypionate (TC). Thirty-one healthy men were randomized into a dose group of 100, 250, or 500 mg/wk and received 14 weekly injections of TC. A pharmacokinetic/pharmacodynamic (PK/PD) model was developed to characterize testosterone concentrations and link exposure to change in luteinizing hormone and spermatogenesis following long-term TC administration. A linear one-compartment model best described the concentration-time profile of total testosterone. The population mean estimates for testosterone were 2.6 kL/day for clearance and 14.4 kL for volume of distribution. Weight, albumin, and their changes from baseline were identified as significant covariates for testosterone. The estimated potency of total testosterone (tT) with respect to suppression of luteinizing hormone (LH) synthesis was 9.33 ng/mL. Simulation based on the indirect response model suggests the suppression of endogenous testosterone secretion, LH synthesis, and spermatogenesis was more severe and of greater duration in the 250 mg and the 500 mg dose groups.

AB - A randomized, double-blind clinical trial was conducted to investigate long-term abuse effects of testosterone cypionate (TC). Thirty-one healthy men were randomized into a dose group of 100, 250, or 500 mg/wk and received 14 weekly injections of TC. A pharmacokinetic/pharmacodynamic (PK/PD) model was developed to characterize testosterone concentrations and link exposure to change in luteinizing hormone and spermatogenesis following long-term TC administration. A linear one-compartment model best described the concentration-time profile of total testosterone. The population mean estimates for testosterone were 2.6 kL/day for clearance and 14.4 kL for volume of distribution. Weight, albumin, and their changes from baseline were identified as significant covariates for testosterone. The estimated potency of total testosterone (tT) with respect to suppression of luteinizing hormone (LH) synthesis was 9.33 ng/mL. Simulation based on the indirect response model suggests the suppression of endogenous testosterone secretion, LH synthesis, and spermatogenesis was more severe and of greater duration in the 250 mg and the 500 mg dose groups.

UR - http://www.scopus.com/inward/record.url?scp=85045920599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045920599&partnerID=8YFLogxK

U2 - 10.1002/psp4.12287

DO - 10.1002/psp4.12287

M3 - Article

C2 - 29436172

AN - SCOPUS:85045920599

VL - 7

SP - 259

EP - 268

JO - CPT: Pharmacometrics and Systems Pharmacology

JF - CPT: Pharmacometrics and Systems Pharmacology

SN - 2163-8306

IS - 4

ER -